[Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes].
D000547:Amantadine / Q000627:therapeutic use*; D000978:Antiparkinson Agents / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004338:Drug Combinations; D004357:Drug Synergism; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010919:Placebos; D013888:Thiothixene / Q000627:therapeutic use*; D014282:Trihexyphenidyl / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D004338:Drug Combinations; D010919:Placebos; D004295:Dihydroxyphenylalanine; D014282:Trihexyphenidyl; D013888:Thiothixene; D000547:Amantadine
La valeur comparée de la L-Dopa, de l'amantadie, des anticholinegiques et de leurs associations dans les syndromes parkinsoniens.